World Journal of Gastroenterology,
Journal Year:
2024,
Volume and Issue:
31(5)
Published: Dec. 30, 2024
Colorectal
cancer
(CRC)
is
the
third
most
commonly
diagnosed
and
second
leading
cause
of
death
worldwide.
The
risk
factors
for
CRC
include
male
gender,
age
over
50,
family
history,
obesity,
tobacco
smoking,
alcohol
consumption,
unhealthy
diet.
screening
methods
vary
considerably
between
countries
depend
on
incidence,
economic
resources
healthcare
structure.
Important
aspects
adherence,
which
can
significantly
across
ethnic
socioeconomic
groups.
Basic
concepts
pre-stratification
patients
by
identifying
then
using
fecal
immunochemical
test
or
guaiac-based
occult
blood
and/or
colonoscopy
radiologic
imaging
techniques.
Technological
capabilities
are
rapidly
evolving
stool
DNA
test,
liquid
biopsy,
virtual
colonography,
use
artificial
intelligence.
A
prevention
strategy
should
be
comprehensive
active
patient
education
along
with
targeted
implementation
screening.
BMC Cancer,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 16, 2025
Abstract
Background
This
study
aims
to
screen,
validate
novel
biomarkers
and
develop
a
user-friendly
online
tool
for
the
detection
of
colorectal
cancer
(CRC).
Methods
Multi-omics
approach,
comprising
proteomic
analysis
single-cell
transcriptomic
analysis,
was
utilized
discover
candidate
tumor-associated
antigens
(TAAs).
The
presence
autoantibodies
(TAAbs)
in
serum
subsequently
assessed
using
enzyme-linked
immunosorbent
assays
(ELISA)
300
CRC
patients
healthy
controls.
Ten
machine
learning
algorithms
were
diagnostic
models,
with
optimal
one
selected
integrated
into
an
R
Shiny-based
GUI
enhance
usability
accessibility.
Results
We
identified
twelve
potential
TAAs:
HMGA1,
NPM1,
EIF1AX,
CKS1B,
HSP90AB1,
ACTG1,
S100A11,
maspin,
ANXA3,
eEF2,
P4HB,
HKDC1.
ELISA
results
showed
that
five
TAAbs
including
anti-CKS1B,
anti-S100A11,
anti-maspin,
anti-ANXA3,
anti-eEF2
during
evaluation
phase
(all
P
<
0.05).
Random
Forest
model
yielded
AUC
0.82
(95%
CI:
0.78–0.88)
on
training
set
0.75
0.68–0.82)
test
set,
demonstrating
robustness
results.
Web-based
implementations
tools
are
publicly
accessible
via
weblink
https://qzan.shinyapps.io/CRCPred/
.
Conclusions
A
biomarker
panel
can
server
as
complementary
CEA
CA19-9
detection.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 8, 2025
The
important
function
of
microbiota
as
therapeutic
modulators
and
diagnostic
biomarkers
in
cancer
has
been
shown
by
recent
developments
microbiome
research.
intricate
interplay
between
the
gut
development
cancer,
especially
colorectal
breast
cancers,
emphasizes
how
microbial
profiling
may
be
used
for
precision
treatment
early
diagnosis.
Important
signatures,
including
Bacteroides
fragilis
Fusobacterium
nucleatum
,
have
linked
to
progression
providing
information
on
processes
behind
carcinogenesis.
Additionally,
influence
effectiveness
treatments
such
immunotherapy
chemotherapy
highlights
its
dual
improving
outcomes
reducing
side
effects.
To
optimize
results,
strategies
dietary
changes
fecal
transplantation
(FMT)
are
being
investigated.
Despite
these
developments,
there
still
issues,
individual
variations
composition,
a
lack
standardized
procedures,
requirement
reliable
biomarkers.
Integrating
microbiome-based
diagnostics
with
conventional
approaches,
liquid
biopsies
machine
learning
algorithms,
could
revolutionize
detection
management.
This
review
provides
an
overview
current
understanding
host–microbe
immunological
axis
discusses
emerging
centered
modulation
support
human
health.
Further
research
is
essential
overcome
existing
challenges
fully
realize
promise
microbiota-driven
innovations
oncology.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 3722 - 3722
Published: March 27, 2024
Colorectal
cancer
(CRC)
screening
relies
primarily
on
stool
analysis
to
identify
occult
blood.
However,
its
sensitivity
for
detecting
precancerous
lesions
is
limited,
requiring
the
development
of
new
tools
improve
CRC
screening.
Carcinogenesis
involves
significant
alterations
in
mucosal
epithelium
glycocalyx
that
decisively
contribute
disease
progression.
Building
this
knowledge,
we
examined
patient
series
comprehending
premalignant
lesions,
colorectal
tumors,
and
healthy
controls
T-antigen—a
short-chain
O-glycosylation
proteins
considered
a
surrogate
marker
malignancy
multiple
solid
cancers.
We
found
T-antigen
secretions
dysplastic
as
well
cancer.
In
CRC,
expression
was
associated
with
presence
distant
metastases.
parallel,
analyzed
broad
number
stools
from
individuals
who
underwent
colonoscopy,
which
showed
high
T
expressions
high-grade
dysplasia
carcinomas.
Employing
mass
spectrometry-based
lectin-affinity
enrichment,
identified
total
262
proteins,
67%
potentially
exhibited
altered
glycosylation
patterns
advanced
pre-cancerous
lesions.
Also,
(glyco)proteome
enriched
protein
species
involved
key
biological
processes
linked
humoral
innate
immune
responses.
This
study
offers
thorough
glycoproteome,
laying
groundwork
harnessing
non-invasive
detection.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(19), P. 3377 - 3377
Published: Oct. 2, 2024
Background:
The
use
of
fluorescence
agents
and
imaging
systems
is
a
promising
adjunct
in
the
surgical
management
colorectal
cancer.
This
systematic
review
meta-analysis
aimed
to
assess
safety
efficacy
fluorescence-guided
surgery
cancer,
with
comparison
conventional
(non-fluorescence-guided)
surgery.
Methods:
A
literature
search
MEDLINE,
Embase,
Emcare,
CINAHL
databases
was
performed
for
studies
that
reported
data
on
outcomes
surgery,
or
without
group
undergoing
cancer
between
January
2000
2024.
using
random-effect
models,
between-study
heterogeneity
assessed.
Results:
35
3217
patients
were
included:
26
(964
patients)
9
(2253
versus
weighted
mean
detection
rate
71%
(95%
CI
0.55–0.85),
no
significant
difference
lymph
node
yield
ratio
(WMD
−0.04;
95%
−0.10–0.02;
p
=
0.201)
groups.
There
significantly
lower
blood
loss
−4.38;
−7.05–−1.70;
0.001)
complication
−0.07–0.00;
0.027)
group,
potentially
anastomotic
leak
−0.05;
−0.10–0.01;
0.092).
Conclusions:
Fluorescence-guided
safe
effective
approach
reducing
complications.
Further
randomised
controlled
trials
are
required
comparing
determine
its
prognostic
benefit
where
it
should
precisely
fit
within
pathway
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(10), P. e0308009 - e0308009
Published: Oct. 29, 2024
Objective
This
study
investigated
the
relationship
between
long
non-coding
RNA
Metastasis-Associated
Lung
Adenocarcinoma
Transcript
1
(MALAT1)
expression
and
colorectal
cancer
(CRC)
using
a
thorough
systematic
review
meta-analysis.
Methods
Under
PRISMA
guidelines,
was
conducted
on
studies
published
from
databases’
inception
to
September
18,
2023.
Prognostic
value
diagnostic
accuracy
were
explored.
Additionally,
association
levels
of
MALAT1
pathological
features
investigated.
The
statistical
analysis
performed
“meta”
package
R.
Results
Among
parameters
examined,
based
three
involving
51
cases
metastatic
CRC
135
non-metastatic
CRC,
statistically
significant
correlation
found
level
distant
metastasis,
with
an
OR
16.0118
(95%
CI:
4.5618–56.2015).
Three
378
reported
overall
survival
had
pooled
HR
2.3854
1.3272–4.2875).
436
disease-free
2.4772
1.3774–4.4549).
All
prognosis
utilized
tumor
tissue
samples
as
specimens
assess
MALAT1.
Case-to-control
126
controls
AUC
0.6173
0.5436–0.6909),
sensitivity
0.675
0.324–0.900),
specificity
0.771
0.685–0.839).
Conclusions
in
is
highly
correlated
metastasis
has
impact
prognosis.
could
also
be
employed
biomarker.
More
prospective
should
potential
early
stages
CRC.